首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1821533

2025年全球輔助生殖技術市場報告

Assisted Reproductive Technology Global Market Report 2025

出版日期: 2025年09月10日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年輔助生殖技術市場規模將強勁成長，到2029年將達到524.2億美元，複合年成長率為9.1%。預測期間的成長可歸因於母親年齡成長、同性育兒需求成長、醫療旅遊、醫療基礎設施建設以及研發投入。預測期內的主要趨勢包括人工智慧 (AI) 的應用、卵子冷凍、單一胚胎移植 (SET)、PGT-A 和基因篩檢，以及創新的生育力保存技術。

未來五年9.1%的成長率預測比我們先前的預測略有下降0.2個百分點。這一下降主要源自於美國與其他國家之間關稅的影響。關稅上漲可能會增加來自丹麥和比利時的試管嬰兒孵化器和胚胎監測系統的價格，從而加劇生育治療的成本，並限制生育選擇，從而對美國的生育服務造成壓力。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也可能更為廣泛。

隨著不孕症患者數量的不斷增加，輔助生殖技術市場預計將持續成長。根據世界衛生組織（WHO）2023年4月的報告，不孕症（即在嘗試懷孕一年後才被診斷出患有不孕症）影響著全球相當一部分成年人口，約六分之一的成年人，全球約有17.5%的人受此影響。因此，不孕症盛行率的上升正在推動對輔助生殖技術（ART）的需求，該技術包括影響男性和女性生殖功能的不孕症治療。

全球輔助生殖科技：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
最終用途產業分析
全球輔助生殖技術市場：成長率分析
全球輔助生殖技術市場表現：規模與成長，2019-2024
全球輔助生殖技術市場預測：規模與成長，2024-2029年，2034年
全球輔助生殖技術：總目標市場（TAM）

第6章市場細分

全球輔助生殖技術市場（按診斷、實際和預測），2019-2024 年、2024-2029 年、2034 年
排卵測試
造影
卵巢儲備測試
基因檢測
全球輔助生殖技術市場（按程序類型、實際和預測），2019-2024 年、2024-2029 年、2034 年
新鮮非供體
新捐款者
凍結捐贈者
冷凍非捐贈者
胚胎或卵子庫
全球輔助生殖技術市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
醫院
不孕不育診所
其他最終用戶
全球輔助生殖技術市場：按排卵測試類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
尿液排卵預測套件
唾液排卵檢測套組
全球輔助生殖技術市場：子宮造影造影 (HSG) 細分、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
X光子宮輸卵管攝影
子宮腔超音波造影（SHG）
全球輔助生殖技術市場：卵巢儲備測試細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
濾泡刺激素（FSH）檢測
抗穆氏管荷爾蒙(AMH) 測試
超音波竇卵泡計數（AFC）
全球輔助生殖技術市場：依基因檢測類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
胚胎胚胎著床前基因檢測（PGT）
攜帶者篩檢測試
基因相容性測試

第7章區域和國家分析

全球輔助生殖技術市場：按地區、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
全球輔助生殖技術市場：按國家、實際結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

輔助生殖技術市場：競爭格局
輔助生殖科技市場：公司簡介
- Cooper Surgical Inc. Overview, Products and Services, Strategy and Financial Analysis
- Ferring Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Hamilton Thorne Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- Genea Limited Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

California Cryobank
European Sperm Bank
OvaScience Inc.
Bloom IVF Centre
Vitrolife AB
FUJIFILM Irvine Scientific Inc.
Nidacon International AB
Monash IVF Group Ltd.
Cook Medical
INVO Bioscience Inc.
Thermo Fisher Scientific Inc.
Boston Scientific Corporation
Anecova Sa
Carolinas Fertility Institute
Microm Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029年輔助生殖市場：提供新機會的國家
2029年輔助生殖科技市場：細分領域帶來新機會
2029年輔助生殖科技市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r21027u

Assisted reproductive technology (ART) involves surgically removing eggs from women's ovaries, combining them with men's sperm in a laboratory to form embryos, and then reintroducing these embryos into the woman's body. ART procedures may utilize donor eggs, donor sperm, or previously stored frozen embryos, and they are employed in the treatment of infertility related to eggs or embryos.

The primary types of assisted reproductive technology include in-vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo replacement (FER), and other related procedures. In-vitro fertilization (IVF) is a complex process wherein eggs are retrieved, fertilized with sperm in a laboratory to create embryos, and then implanted into the reproductive organs of women. Procedure types within ART encompass fresh non-donor, fresh donor, frozen donor, frozen non-donor, as well as embryo or egg banking. These technologies find application in various healthcare settings, including hospitals, fertility clinics, and other related facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The assisted reproductive technology (ART) market research report is one of a series of new reports from The Business Research Company that provides assisted reproductive technology (ART) market statistics, including assisted reproductive technology (ART) industry global market size, regional shares, competitors with a assisted reproductive technology (ART) market share, detailed assisted reproductive technology (ART) market segments, market trends and opportunities, and any further data you may need to thrive in the assisted reproductive technology (ART) industry. This assisted reproductive technology (ART) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The assisted reproductive technology market size has grown strongly in recent years. It will grow from $34.35 billion in 2024 to $37.06 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increase in infertility rates, changing societal norms, growing awareness, legislative support, aging population.

The assisted reproductive technology market size is expected to see strong growth in the next few years. It will grow to $52.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing maternal age, rising demand for same-sex parenting, medical tourism, expanding healthcare infrastructure, research and development. Major trends in the forecast period include use of artificial intelligence (AI), egg freezing, single-embryo transfer (SET), PGT-A and genetic screening, innovative fertility preservation techniques.

The forecast of 9.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. fertility treatments by driving up the cost of IVF incubators and embryo monitoring systems sourced from Denmark and Belgium, exacerbating infertility treatment costs and limiting family-building options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The assisted reproductive technology market is anticipated to experience growth due to the increasing number of infertility cases. Infertility, diagnosed after a year of unsuccessful attempts to conceive, impacts a significant portion of the global adult population, affecting approximately 1 in 6 adults or 17.5% globally, as stated by the World Health Organization in April 2023. As a result, the rising prevalence of infertility cases is propelling the demand for assisted reproductive technology (ART), which encompasses fertility treatments involving both male and female reproductive components.

The escalating prevalence of obesity is poised to drive the growth of the ART market in the future. Obesity, characterized by excessive body fat accumulation that may affect health, can lead to irregular menstrual cycles, ovulatory dysfunction, and decreased sperm quality, thereby increasing infertility risks. The World Heart Federation reported in March 2023 that around 2.3 billion individuals, including adults and children, were affected by obesity or being overweight globally. Projections indicate that by 2025, this number may soar to 2.7 billion, underscoring the significant impact of obesity on fertility and the subsequent demand for specialized ART services.

A prominent trend shaping the ART market is the advancement of technology. Leading companies are actively developing technological solutions to fortify their positions within the industry. Notably, Alife Health introduced the Alife Assist platform in October 2022, an innovative suite of products leveraging data-driven insights and artificial intelligence (AI) to transform the in-vitro fertilization (IVF) process. This platform, consisting of Stim Assist, Embryo Assist, and Insights, caters to reproductive endocrinologists, embryologists, and clinic administrators, aiding in clinical decision-making, streamlining IVF clinic operations, and optimizing medication dosing, embryo grading, and real-time performance monitoring. The implementation of such technology not only enhances the patient experience but also improves success rates in IVF procedures.

Leading companies in the assisted reproductive technology (ART) sector are spearheading the development of innovative products to gain a competitive edge in the market. For example, in July 2023, Thermo Fisher Scientific Inc., a renowned US-based biotechnology firm, introduced two pioneering next-generation sequencing-based options specifically crafted to support preimplantation genetic testing-aneuploidy (PGT-A) in the context of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research. The cutting-edge products, namely the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, are tailored for use in reproductive health labs. These are the first research-use assays in the field, and they are compatible with the Ion Torrent Genexus Integrated Sequencer, providing a comprehensive workflow from the initial sample to the final result for aneuploidy analysis. PGT-A testing facilitates the identification of chromosomal irregularities in embryo samples, offering researchers invaluable genetic insights to potentially bolster the success rate of future pregnancies and improve the health of future generations. The Genexus Integrated Sequencer streamlines the research process by enabling templating, sequencing, and analysis on a single platform. Additionally, the Ion AmpliSeq Polyploidy Panel kit includes quality control features designed to detect contamination, prevent sample mix-ups, and identify triploidy in embryos.

In November 2023, CooperCompanies, a US-based medical device firm, acquired Cook Medical's Reproductive Health business for $300 million. The products obtained in this acquisition complement CooperSurgical's current portfolio of medical devices and strengthen the company's position as a leading global provider in the fields of fertility and women's health. Cook Medical is a US-based supplier of assisted reproductive technology.

Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois

Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology (ART) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the assisted reproductive technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The assisted reproductive technology market includes revenues earned by entities by gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), and frozen embryo transfer (FET). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Assisted Reproductive Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on assisted reproductive technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for assisted reproductive technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The assisted reproductive technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing
2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking
3) By End-User: Hospitals; Fertility Clinics; Other End-Users
Subsegments:
1) By Ovulation Testing: Urine Ovulation Predictor Kits; Saliva Ovulation Test Kits
2) By Hysterosalpingography (HSG): X-ray HSG; Sonohysterography (SHG)
3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing; Anti-Mullerian Hormone (AMH) Testing; Antral Follicle Count (AFC) via Ultrasound
4) By Genetic Testing: Preimplantation Genetic Testing (PGT); Carrier Screening Tests; Genetic Compatibility Testing
Companies Mentioned: Cooper Surgical Inc.; Ferring Pharmaceuticals Ltd.; Hamilton Thorne Ltd.; Merck KGaA; Genea Limited; California Cryobank; European Sperm Bank; OvaScience Inc.; Bloom IVF Centre; Vitrolife AB; FUJIFILM Irvine Scientific Inc.; Nidacon International AB; Monash IVF Group Ltd.; Cook Medical; INVO Bioscience Inc.; Thermo Fisher Scientific Inc.; Boston Scientific Corporation; Anecova Sa; Carolinas Fertility Institute; Microm Ltd.; Inception Sciences Inc.; Progyny Inc.; Oxford Gene Technology IP Ltd.; IVI-RMA Global; Boston IVF; CARE Fertility Group; Virtus Health; Reproductive Medicine Associates of New York; Shady Grove Fertility; CCRM Fertility; New Hope Fertility Center; Houston Fertility Institute; Pacific Fertility Center; RMA of New Jersey; Sher Fertility Institute; IVF Florida; ORM Fertility; HRC Fertility; Arizona Center for Reproductive Endocrinology & Infertility; San Diego Fertility Center; Fertility Centers of Illinois
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Assisted Reproductive Technology Market Characteristics

3. Assisted Reproductive Technology Market Trends And Strategies

4. Assisted Reproductive Technology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Assisted Reproductive Technology Growth Analysis And Strategic Analysis Framework

5.1. Global Assisted Reproductive Technology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Assisted Reproductive Technology Market Growth Rate Analysis
5.4. Global Assisted Reproductive Technology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Assisted Reproductive Technology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Assisted Reproductive Technology Total Addressable Market (TAM)

6. Assisted Reproductive Technology Market Segmentation

6.1. Global Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ovulation Testing
Hysterosalpingography
Ovarian Reserve Testing
Genetic Testing
6.2. Global Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fresh Non-Donor
Fresh Donor
Frozen Donor
Frozen Non-Donor
Embryo Or Egg Banking
6.3. Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Fertility Clinics
Other End-Users
6.4. Global Assisted Reproductive Technology Market, Sub-Segmentation Of Ovulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urine Ovulation Predictor Kits
Saliva Ovulation Test Kits
6.5. Global Assisted Reproductive Technology Market, Sub-Segmentation Of Hysterosalpingography (HSG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
X-ray HSG
Sonohysterography (SHG)
6.6. Global Assisted Reproductive Technology Market, Sub-Segmentation Of Ovarian Reserve Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Follicle Stimulating Hormone (FSH) Testing
Anti-Mullerian Hormone (AMH) Testing
Antral Follicle Count (AFC) via Ultrasound
6.7. Global Assisted Reproductive Technology Market, Sub-Segmentation Of Genetic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preimplantation Genetic Testing (PGT)
Carrier Screening Tests
Genetic Compatibility Testing

7. Assisted Reproductive Technology Market Regional And Country Analysis

7.1. Global Assisted Reproductive Technology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Assisted Reproductive Technology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Assisted Reproductive Technology Market

8.1. Asia-Pacific Assisted Reproductive Technology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Assisted Reproductive Technology Market

9.1. China Assisted Reproductive Technology Market Overview
9.2. China Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Assisted Reproductive Technology Market

10.1. India Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Assisted Reproductive Technology Market

11.1. Japan Assisted Reproductive Technology Market Overview
11.2. Japan Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Assisted Reproductive Technology Market

12.1. Australia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Assisted Reproductive Technology Market

13.1. Indonesia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Assisted Reproductive Technology Market

14.1. South Korea Assisted Reproductive Technology Market Overview
14.2. South Korea Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Assisted Reproductive Technology Market

15.1. Western Europe Assisted Reproductive Technology Market Overview
15.2. Western Europe Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Assisted Reproductive Technology Market

16.1. UK Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Assisted Reproductive Technology Market

17.1. Germany Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Assisted Reproductive Technology Market

18.1. France Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Assisted Reproductive Technology Market

19.1. Italy Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Assisted Reproductive Technology Market

20.1. Spain Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Assisted Reproductive Technology Market

21.1. Eastern Europe Assisted Reproductive Technology Market Overview
21.2. Eastern Europe Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Assisted Reproductive Technology Market

22.1. Russia Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Assisted Reproductive Technology Market

23.1. North America Assisted Reproductive Technology Market Overview
23.2. North America Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Assisted Reproductive Technology Market

24.1. USA Assisted Reproductive Technology Market Overview
24.2. USA Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Assisted Reproductive Technology Market

25.1. Canada Assisted Reproductive Technology Market Overview
25.2. Canada Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Assisted Reproductive Technology Market

26.1. South America Assisted Reproductive Technology Market Overview
26.2. South America Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Assisted Reproductive Technology Market

27.1. Brazil Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Assisted Reproductive Technology Market

28.1. Middle East Assisted Reproductive Technology Market Overview
28.2. Middle East Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Assisted Reproductive Technology Market

29.1. Africa Assisted Reproductive Technology Market Overview
29.2. Africa Assisted Reproductive Technology Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Assisted Reproductive Technology Market, Segmentation By Procedure Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Assisted Reproductive Technology Market Competitive Landscape And Company Profiles

30.1. Assisted Reproductive Technology Market Competitive Landscape
30.2. Assisted Reproductive Technology Market Company Profiles
- 30.2.1. Cooper Surgical Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Ferring Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Hamilton Thorne Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Genea Limited Overview, Products and Services, Strategy and Financial Analysis

31. Assisted Reproductive Technology Market Other Major And Innovative Companies

31.1. California Cryobank
31.2. European Sperm Bank
31.3. OvaScience Inc.
31.4. Bloom IVF Centre
31.5. Vitrolife AB
31.6. FUJIFILM Irvine Scientific Inc.
31.7. Nidacon International AB
31.8. Monash IVF Group Ltd.
31.9. Cook Medical
31.10. INVO Bioscience Inc.
31.11. Thermo Fisher Scientific Inc.
31.12. Boston Scientific Corporation
31.13. Anecova Sa
31.14. Carolinas Fertility Institute
31.15. Microm Ltd.

32. Global Assisted Reproductive Technology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Assisted Reproductive Technology Market

34. Recent Developments In The Assisted Reproductive Technology Market

35. Assisted Reproductive Technology Market High Potential Countries, Segments and Strategies

35.1 Assisted Reproductive Technology Market In 2029 - Countries Offering Most New Opportunities
35.2 Assisted Reproductive Technology Market In 2029 - Segments Offering Most New Opportunities
35.3 Assisted Reproductive Technology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies